Effect of indomethacin on E-cadherin and β-catenin expression in HT-29 colon cancer cells

Experimental and Molecular Pathology

Volumn 80, Issue 1, 2006, Pages 91-96

  Kapitanović, Sanja ^a   Čačev, Tamara ^a   Antica, Mariastefania ^a   Kralj, Marijeta ^a   Cavrić, Gordana ^a   Pavelić, Krešimir ^a   Spaventi, Radan ^b  

^a RUDER BO KOVI INSTITUTE   (Croatia)

^b PLIVA Research Institute Ltd   (Croatia)

Author keywords

catenin; APC; Colon carcinoma; COX 2; E cadherin; HT 29; Indomethacin

Indexed keywords

BETA CATENIN; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; UVOMORULIN; WNT PROTEIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL PROLIFERATION; CELL STRAIN HT29; COLON CANCER; CONCENTRATION RESPONSE; DRUG EFFECT; DRUG MECHANISM; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ACTIVE TRANSPORT, CELL NUCLEUS; ADAPTOR PROTEINS, VESICULAR TRANSPORT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTINEOPLASTIC AGENTS; APOPTOSIS; BETA CATENIN; CADHERINS; CELL MEMBRANE; CELL NUCLEUS; CELL PROLIFERATION; COLONIC NEOPLASMS; CYCLOOXYGENASE 2; CYTOPLASM; HT29 CELLS; HUMANS; INDOMETHACIN; MEMBRANE PROTEINS; SIGNAL TRANSDUCTION; WNT PROTEINS;

EID: 29244480305     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2005.04.008     Document Type: Article

References (16)

1. U. Cavallaro, B. Schaffhauser, and G. Christofori Cadherins and the tumour progression: is it all in a switch Cancer Lett. 176 2002 123 128
2. G.E. Eberhart, R.J. Coffey, A. Radhika, F.M. Giardiello, S. Ferrenbach, and R.N. Dubois Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinoma Gastroenterology 107 1994 1183 1188
3. M.C. Faux, J.L. Ross, C. Meeker, T. Johns, H. Ji, R.J. Simpson, M.J. Layton, and A.W. Burgess Restoration of full-length adenomatous polyposis coli (APC) protein in a colon cancer cell line enhances cell adhesion J. Cell. Sci. 117 2004 427 439
4. N.C. Fearnhead, M.P. Britton, and W.F. Bodmer The ABC of APC Hum. Mol. Genet. 10 2001 721 733
5. E.R. Fearon Genetic alterations underlaying colorectal tumorigenesis Cancer Surv. 12 1992 119 136
6. F.G. Giardiello, S.R. Hamilton, A.J. Krush, S. Piantadosi, L.M. Hylind, P. Celano, S.V. Booker, C.R. Robinson, and G.A. Offerhaus Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis N. Engl. J.Med. 328 1993 1313 1316
7. R.H. Giles, J.H. van Es, and H. Clevers Caught up in a Wnt storm: Wnt signaling in cancer Biochim. Biophys. Acta 1653 2003 1 24
8. T. Kawamori, C.V. Rao, K. Seibert, and B.S. Reddy Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis Cancer Res. 58 1998 409 412
9. A.R. Kinsella, G.C. Lepts, C.L. Hill, and M. Jones Reduced E-cadherin expression correlates with increased invasiveness in colorectal carcinoma cell lines Clin. Exp. Metastasis 12 1994 335 342
10. K.W. Kinzler, and B. Vogelstein Lessons from hereditary colorectal cancer Cell. 87 1996 159 170
11. M. Kralj, S. Kapitanović, D. Kovačević, J. Lukač, Š. Spaventi, and K. Pavelić Effect of nonsteroidal anti-inflammatory drug indomethacin on proliferation and apoptosis of colon carcinoma cells J. Cancer Res. Clin. Oncol. 127 2001 173 179
12. M. Langman, and P. Boyle Chemoprevention of colorectal cancer Gut 43 1998 578 585
13. T.J. Maier, K. Schilling, R. Schmidt, G. Geisslinger, and S. Grösch Cyclooxygenase-2 (COX-2)-dependent and -independent anticarcinogenic effects of celecoxib in human colon carcinoma cells Biochem. Pharmacol. 67 2004 1469 1478
14. C.V. Rao, A. Rivenson, B. Simi, E. Zang, G. Kelloff, V. Steele, and B.S. Reddy Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent Cancer Res. 55 1995 1464 1472
15. H. Sano, K. Kawahito, R.L. Wilder, A. Hashiramoto, S. Mukai, K. Assai, S. Kimura, H. Kato, M. Kondo, and T. Hla Expression of cyclooxygenase-1 and -2 in human colorectal cancer Cancer Res. 55 1995 2556 2559
16. S.J. Shiff, L. Qiao, L.-L. Tsai, and B. Rigas Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells J. Clin. Invest. 96 1995 491 503